|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsor: | ALTANA Pharma |
|---|---|
| Information provided by: | ALTANA Pharma |
| ClinicalTrials.gov Identifier: | NCT00062582 |
Purpose
The aim of the study is to compare the effect of roflumilast and placebo on the lung function in patients with COPD.
| Condition | Intervention | Phase |
|---|---|---|
|
Chronic Obstructive Pulmonary Disease COPD |
Drug: Roflumilast |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment |
| Official Title: | A 24 Week, Placebo-Controlled, Randomized, Parallel Group Study Comparing Roflumilast 500 Mcg Daily vs Placebo on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Main Inclusion Criteria:
Main Exclusion Criteria:
Contacts and Locations
Hide Study Locations| United States, Alabama | |
| ALTANA Pharma | |
| Cities in Alabama, Alabama, United States | |
| United States, Arizona | |
| ALTANA Pharma | |
| Cities in Arizona, Arizona, United States | |
| United States, California | |
| ALTANA Pharma | |
| Cities in California, California, United States | |
| United States, Colorado | |
| ATLANA Pharma | |
| Cities in Colorado, Colorado, United States | |
| United States, Connecticut | |
| ALTANA Pharma | |
| Cities in Conneticut, Connecticut, United States | |
| United States, Delaware | |
| ALTANA Pharma | |
| Cities in Delaware, Delaware, United States | |
| United States, Florida | |
| ALTANA Pharma | |
| Cities in Florida, Florida, United States | |
| United States, Georgia | |
| ALTANA Pharma | |
| Cities in Georgia, Georgia, United States | |
| United States, Idaho | |
| ALTANA Pharma | |
| Cities in Idaho, Idaho, United States | |
| United States, Indiana | |
| ALTANA Pharma | |
| Cities in Indiana, Indiana, United States | |
| United States, Iowa | |
| ALTANA Pharma | |
| Cities in Iowa, Iowa, United States | |
| United States, Kansas | |
| ALTANA Pharma | |
| Cities in Kansas, Kansas, United States | |
| United States, Kentucky | |
| ALTANA Pharma | |
| Cities in Kentucky, Kentucky, United States | |
| United States, Louisiana | |
| ALTANA Pharma | |
| Cities in Louisiana, Louisiana, United States | |
| United States, Maryland | |
| ALTANA Pharma | |
| Cities in Maryland, Maryland, United States | |
| United States, Michigan | |
| ALTANA Pharma | |
| Cities in Michigan, Michigan, United States | |
| United States, Missouri | |
| ALTANA Pharma | |
| Cities in Missouri, Missouri, United States | |
| United States, Nebraska | |
| ALTANA Pharma | |
| Cities in Nebraska, Nebraska, United States | |
| United States, Nevada | |
| ALTANA Pharma | |
| Cities in Nevada, Nevada, United States | |
| United States, New Jersey | |
| ALTANA Pharma | |
| Cities in New Jersey, New Jersey, United States | |
| United States, New York | |
| ALTANA Pharma | |
| Cities in New York, New York, United States | |
| United States, North Carolina | |
| ALTANA Pharma | |
| Cities in North Carolina, North Carolina, United States | |
| United States, Ohio | |
| ALTANA Pharma | |
| Cities in Ohio, Ohio, United States | |
| United States, Oregon | |
| ALTANA Pharma | |
| Cities in Oregon, Oregon, United States | |
| United States, Pennsylvania | |
| ALTANA Pharma | |
| Cities in Pennsylvania, Pennsylvania, United States | |
| United States, Rhode Island | |
| ALTANA Pharma | |
| Cities in Rhode Island, Rhode Island, United States | |
| United States, South Carolina | |
| ALTANA Pharma | |
| Cities in South Carolina, South Carolina, United States | |
| United States, Texas | |
| ALTANA Pharma | |
| Cities in Texas, Texas, United States | |
| United States, Utah | |
| ALTANA Pharma | |
| Cities in Utah, Utah, United States | |
| United States, Virginia | |
| ALTANA Pharma | |
| Cities in Virginia, Virginia, United States | |
| United States, Washington | |
| ALTANA Pharma | |
| Cities in Washington, Washington, United States | |
| United States, West Virginia | |
| ALTANA Pharma | |
| Cities in West Virginia, West Virginia, United States | |
| Argentina | |
| ALTANA Pharma | |
| Cities in Argentina, Argentina | |
| Canada | |
| ALTANA Pharma | |
| Cities in Canada, Canada | |
| Colombia | |
| ALTANA Pharma | |
| Cities in Colombia, Colombia | |
| Mexico | |
| ALTANA Pharma | |
| Cities in Mexico, Mexico | |
| Peru | |
| ALTANA Pharma | |
| Cities in Peru, Peru | |
| Principal Investigator: | Douglas S. Helmersen, Prof. Dr. | Peter Lougheed Center; 3500-26th Ave. NE, Calgary, Canada |
More Information
| Study ID Numbers: | BY217/M2-110 |
| Study First Received: | June 9, 2003 |
| Last Updated: | December 15, 2006 |
| ClinicalTrials.gov Identifier: | NCT00062582 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
Roflumilast Chronic Obstructive Pulmonary Disease COPD |
|
Signs and Symptoms Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases |
Respiration Disorders Signs and Symptoms, Respiratory Pulmonary Disease, Chronic Obstructive |
